-
Mashup Score: 2Testing for Hypercoagulability in Patients With Unexplained Arterial Thromboembolism∗ : - 8 month(s) ago
Corresponding Author
Source: www.jacc.orgCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 2Opioids Associated With Increased Risk for Mortality and VTE vs NSAIDs Among Patients With RA - 8 month(s) ago
Investigators assessed risks for major adverse cardiovascular events among patients with rheumatoid arthritis treated with opioids vs nonsteroidal anti-inflammatory drugs.
Source: www.rheumatologyadvisor.comCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A new study found that opioids are linked with an increased risk for all-cause mortality & #cvVTE. Opioids display similar risk profiles for MACE compared w/ NSAIDs for patients with rheumatoid arthritis, the findings suggest. https://t.co/QZS9BR5q8J @RheumAdvisor #CardioTwitter
-
-
Mashup Score: 2Thromboprophylaxis After COVID-19 Hospitalization - American College of Cardiology - 12 month(s) ago
Geoffrey D. Barnes, MD, MSc, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Q: Is anticoagulation superior to placebo in reducing the risk of death & thromboembolic complications after hospital discharge for #COVID19 infection? A: COVID-19–related hospitalizations & associated risks of thromboembolism are relatively low. https://t.co/mN0GpZ5gJg #cvVTE
-
-
Mashup Score: 1
A study was conducted to determine the safety and efficacy of edoxaban therapy in pediatric patients with cardiac disease.
Source: The Cardiology AdvisorCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Among pediatric patients w/ cardiac disease who are at risk for thromboembolism, edoxaban is an appropriate alternative to standard-of-care anticoagulants for preventing TE events, a #JACC study suggests. Read more in @CardioAdvisor: https://t.co/FXfzqWvCNb #cvPrev #cvVTE
-
-
Mashup Score: 0
We are grateful to these distinguished faculty who contributed to this collection: Faculty Chairs: Geoffrey Barnes, MD, MSc, FACC Stanislav Henkin, MD, MPH, FACC Faculty: Anastasia Armbruster, PharmD, FACC Craig J. Beavers, PharmD, FACC Teresa L. Carman, MD Robert D. McBane II, MD Jordan Schaefer, MD
Source: learn.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Determine the optimal evidence-based prophylaxis anticoagulant therapy especially in special populations including cancer and post-procedural patients w/ #ACCEd. Learn more from #cvVTE online course. 🔗 https://t.co/Cggwq4iQAR #CardioTwitter #cvCoag https://t.co/v8HHXAUXHf
-
-
Mashup Score: 55Direct Oral Anticoagulants vs Vitamin K Antagonists in Patients With Antiphospholipid Syndromes: Meta-Analysis of Randomized Trials - 1 year(s) ago
Abstract Background The efficacy and safety of direct oral anticoagulants (DOACs) for patients with thrombotic antiphospholipid syndrome remain controversial. Objectives The authors performed a sys…
Categories: Expert Picks, Latest HeadlinesTweet-
In this meta-analysis of #RCTs of patients with thrombotic #antiphospholipid syndrome, treatment with #DOACs had a higher risk of arterial thrombosis than #VKAs. https://t.co/DlOMgJ9g84 #JACC #VTE #cvVTE #CardioTwitter https://t.co/b7DjwEmhMT
-
-
Mashup Score: 2
We are grateful to these distinguished faculty who contributed to this collection: Faculty Chairs: Geoffrey Barnes, MD, MSc, FACC Stanislav Henkin, MD, MPH, FACC Faculty: Anastasia Armbruster, PharmD, FACC Craig J. Beavers, PharmD, FACC Teresa L. Carman, MD Robert D. McBane II, MD Jordan Schaefer, MD
Source: learn.acc.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Identify comorbidities that influence #cvCoag treatment strategies such as dose adjustments & avoiding underdosing within a multidisciplinary framework w/ the case challenge, Preventing & Treating #cvVTE. Learn at your own pace w/ #ACCEd: https://t.co/Cggwq4iQAR #CardioTwitter https://t.co/ZiNrHsUifP
-
-
Mashup Score: 6The Value of Performance Status in Predicting Clinical Outcomes in Patients With Cancer-Associated Pulmonary Embolism∗ : - 1 year(s) ago
Corresponding Author
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Interesting #JACCCardioOnc editorial discussing the value of the @eaonc performance score in cancer patients with #VTE: https://t.co/tCWyByCCJF #CardioOnc #cvVTE #DVT #CardioTwitter
-
-
Mashup Score: 4
Abstract Background Renal cell carcinoma (RCC) can be complicated by a venous tumor thrombus (TT), of which the optimal management is unknown. Objectives This study sought to assess the prevalence …
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
A tumor thrombus is relatively common in renal cell carcinoma patients, & is associated w/ high risk of developing #VTE. Future studies should establish which of these patients benefit from anticoagulation therapy. https://t.co/agMpnCU5Ua #JACCCardioOnc #CardioOnc #cvVTE #cvCoag https://t.co/yVA53KoMki
-
-
Mashup Score: 6Performance Status and Long-Term Outcomes in Cancer-Associated Pulmonary Embolism: Insights From the Hokusai-VTE Cancer Study - 1 year(s) ago
Abstract Background Performance status (PS) is a reliable prognostic tool for overall survival in patients with cancer-associated pulmonary embolism (PE). However, its association with venous throm…
Source: JACC: CardioOncologyCategories: Expert Picks, Latest HeadlinesTweet-
Performance Score is a valuable indicator for predicting #VTE-related outcomes and may inform decision-making regarding anticoagulation during follow-up in patients with cancer-associated PE. https://t.co/sjKy374aZt #JACCCardioOnc #CardioOnc #cvVTE #cvCoag #ECOG #CardioTwitter https://t.co/HBywvtdgC5
-
Learn how to consider testing hypercoagulability in young patients with unexplained arterial #thromboembolism in #JACCCaseReports: https://t.co/5elJXUj4eV #CardioTwitter #CathLab #cvMI #cvVTE https://t.co/3jtCSO8HLM